New Directions in the Diagnosis and Treatment of Hematologic Cancers: Highlights from International Medical Meetings
June 14, 2023
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, these enduring materials review cutting-edge updates and perspectives on new diagnostic tools and management options of hematologic malignancies. Courses include genetic profiling, cytogenetics, molecular diagnostics, risk adaptive strategies, and novel therapies recently approved by the FDA.
CME credit is no longer available for the following enduring content.